John J. Treanor

1989–2024 年に発表

108
論文数
24,306
被引用数
84
h 指数
106
i10 指数

被引用数

John J. Treanor の年別被引用数1990 年: 被引用 1 件1991 年: 被引用 3 件1992 年: 被引用 7 件1993 年: 被引用 1 件1994 年: 被引用 6 件1995 年: 被引用 13 件1996 年: 被引用 14 件1997 年: 被引用 32 件1998 年: 被引用 38 件1999 年: 被引用 67 件2000 年: 被引用 118 件2001 年: 被引用 141 件2002 年: 被引用 107 件2003 年: 被引用 116 件2004 年: 被引用 134 件2005 年: 被引用 130 件2006 年: 被引用 182 件2007 年: 被引用 149 件2008 年: 被引用 231 件2009 年: 被引用 222 件2010 年: 被引用 197 件2011 年: 被引用 189 件2012 年: 被引用 171 件2013 年: 被引用 216 件2014 年: 被引用 172 件2015 年: 被引用 140 件2016 年: 被引用 135 件2017 年: 被引用 150 件2018 年: 被引用 197 件2019 年: 被引用 635 件2020 年: 被引用 640 件2021 年: 被引用 967 件2022 年: 被引用 859 件2023 年: 被引用 407 件2024 年: 被引用 584 件2025 年: 被引用 276 件2026 年: 被引用 4 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,297 件、この内訳の 33.9%イギリス: 引用元論文 737 件、この内訳の 7.6%中国: 引用元論文 519 件、この内訳の 5.3%カナダ: 引用元論文 397 件、この内訳の 4.1%ドイツ: 引用元論文 342 件、この内訳の 3.5%オーストラリア: 引用元論文 324 件、この内訳の 3.3%オランダ: 引用元論文 309 件、この内訳の 3.2%フランス: 引用元論文 300 件、この内訳の 3.1%イタリア: 引用元論文 265 件、この内訳の 2.7%日本: 引用元論文 216 件、この内訳の 2.2%ベルギー: 引用元論文 182 件、この内訳の 1.9%スペイン: 引用元論文 175 件、この内訳の 1.8%
0%33.9%その他 27.4%

分野

  • Medicine76.6%
  • Immunology and Microbiology7%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Social Sciences2.9%
  • Psychology1.6%
  • Neuroscience1.6%
  • その他4.5%

トピック

  • Influenza Virus Research Studies14.4%
  • Respiratory viral infections research10.7%
  • SARS-CoV-2 and COVID-19 Research8%
  • Viral gastroenteritis research and epidemiology4.7%
  • COVID-19 Clinical Research Studies3.2%
  • Vaccine Coverage and Hesitancy2.9%
  • その他56.1%

共著者

全論文

検索で開く
  1. Influenza

    著者: , , , , , , , , , , - Nature Reviews Disease Primers 2018 被引用: 1,551

  2. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 2,601

  3. Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 867

  4. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains

    著者: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 被引用: 576

  5. Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , - Cell 2018 被引用: 436

  6. Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 250

  7. Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older

    著者: , , , , - The Journal of Infectious Diseases 2009 被引用: 387

  8. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2019 被引用: 165

  9. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

    著者: , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2016 被引用: 276

  10. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)

    著者: , , , , , , , , - Vaccine 2011 被引用: 160

  11. Loneliness, Social Network Size, and Immune Response to Influenza Vaccination in College Freshmen.

    著者: , , , , , - Health Psychology 2005 被引用: 611

  12. Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza

    著者: , , , , , , , , , , - JAMA 2000 被引用: 1,020

  13. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2016 被引用: 247

  14. Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans

    著者: , , , , , , , , , - npj Vaccines 2020 被引用: 59

  15. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

    著者: , , , , , , , - Vaccine 1999 被引用: 272

  16. Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans

    著者: , , , , , , , - Nature Communications 2019 被引用: 99

  17. Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Samba O. Sow, Milagritos D. Tapia, Boubou Tamboura, Ibrahim Tégueté, Sharon M. Tennant, Awa Traoré, John J. Treanor, Janet A. Englund, Joanne Katz, Subarna K. Khatry, Jane Kuypers, Steven C. LeClerq, Luke C. Mullany, Laxman Shrestha, Mark C. Steinhoff, James M. Tielsch, Peter V. Adrian, Clare Cutland, Andrea Hugo, Stephanie Jones, Locadiah Kuwanda, Keith P. Klugman, Shabir A. Madhi, Kathleen M. Neuzil, Nadia van Niekerk, Marta C. Nunes, Justin R. Ortiz, Eric A. F. Simões, Florette K. Treurnicht, Marietjie Venter, Avy Violari, Adriana Weinberg - The Lancet Respiratory Medicine 2020 被引用: 80

  18. Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

    著者: , , , , - New England Journal of Medicine 2006 被引用: 704

  19. Effectiveness of Seasonal Influenza Vaccines in the United States During a Season With Circulation of All Three Vaccine Strains

    著者: , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2012 被引用: 260

  20. Adjuvanted Intranasal Norwalk Virus‐Like Particle Vaccine Elicits Antibodies and Antibody‐Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues

    著者: , , , , , , , , , , , , - The Journal of Infectious Diseases 2010 被引用: 225

  21. FluBlok, a recombinant hemagglutinin influenza vaccine

    著者: , , - Influenza and Other Respiratory Viruses 2008 被引用: 156

  22. Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tina Tong, John J. Treanor, T. Anh Wartel, Carlos A. DiazGranados, Roman M. Chicz, Sanjay Gurunathan, Stephen J. Savarino, Saranya Sridhar, Karina Abalos, José Accini, Naveena Aloysia, John Amuasi, Nana Akosua Ansah, David Benkeser, Aude Berge, Hanna Beyko, Oleksandra Bilotkach, Thomas Breuer, Alberto Cadena Bonfanti, Elisabeth Bukusi, Richard Canter, Jaime Augusto Carrillo, Danaya Chansinghakul, Florence Coux, Chandan Krushna Das, Santa Kumar Das, Louis Devlin, Luis Espinoza, Michael P. Fay, Dean Follmann, Carina Frago, Agnes Garinga, Peter B. Gilbert, Claudia González, Maria Angelica Granados, Lea Guillery, Ying Huang, Kathy Hudzina, Manish Kumar Jain, Piush Kanodia, Nitin Khandelwal, Cissy Kityo Mutuluuza, Francis Kiweewa, Noah Kiwanuka, Chalit Kosolsak, Darshna Kukian, Jitendra Singh Kushwaha, Thelma Laot, Eduardo López-Medina, Hugo Macareno Arroyo, Kishorchandra Mandaliya, Stephanie Mamod, Somnath Mangarule, Javier Martínez, Scott McClelland, Lisa Menard, Sandra Mendoza, Satyajit Mohapatra, Catherine Moreau, Nelly Mugo, Videlis Nduba, Fernando Noriega, Patricia Nahirya Ntege, Brenda Okech, María Calado Otero, Samuel Gurrion Ouma, Janet Oyieko, Mercedes Paredes, Erwin Pardo, Svitlana Postol ほか 22 名 - The Lancet Respiratory Medicine 2023 被引用: 24

  23. Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza

    著者: , , , , , , , , , - JAMA 1999 被引用: 558

  24. Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections

    著者: , , , , , , , , , - New England Journal of Medicine 1997 被引用: 768